← Back to Clinical Trials
Recruiting NCT05425992
NCT05425992 Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT05425992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Leukemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2022-03-17 |
| Primary Completion | 2027-12-31 |
Trial Parameters
Condition Leukemia
Sponsor University of Colorado, Denver
Study Type OBSERVATIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age N/A
Max Age 22 Years
Start Date 2022-03-17
Completion 2027-12-31
All Conditions
Interventions
Interview
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
Eligibility Criteria
Inclusion Criteria: * 0 to 22 years of age * Diagnosis of leukemia or non-Hodgkin lymphoma * Spanish as preferred language for patient, parent or guardian * Received or receiving care at the Center for Cancer and Blood Disorders (CCBD) Exclusion Criteria: * Patients without oncologic diagnosis * Patients with parents whose language preference is English * Patients who received care solely outside of the CCBD
Related Trials
NCT05425992
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
View Trial →
NCT03826992
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemi
View Trial →
NCT02872987
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treat
View Trial →
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology